Analysis of Novel anti-mycobacterial compounds to treat Tuberculosis
Novel anti-mycobacterial peptides to treat Tuberculosis Tuberculosis (TB) remains a major health concern since the 19th century. The widespread emergence of anti-microbial resistance to first- line-TB drugs has caused enormous devastation globally as millions of people suffer from the infectious disease. As a result of drug resistance, the treatment plan is extremely long and can take up to two y
